Quick Answer
CORCEPT THERAPEUTICS INC reported Total Assets of $836.65 million for the year ending 2025.
- CORCEPT THERAPEUTICS INC showed a decrease of -0.5% in Total Assets from 2024 to 2025.
- This data is from CORCEPT THERAPEUTICS INC's annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $52.72 million | Q3 2011: $46.38 million | Q1 2012: $42.89 million | Q2 2012: $38.62 million | Q3 2012: $105.52 million | Q1 2013: $88.14 million | Q2 2013: $79.69 million | Q3 2013: $71.06 million | Q1 2014: $52.83 million | Q2 2014: $44.39 million | Q3 2014: $37.16 million | Q1 2015: $48.22 million | Q2 2015: $48.36 million | Q3 2015: $48.38 million | Q1 2016: $52.91 million | Q2 2016: $56.84 million | Q3 2016: $62.93 million | Q1 2017: $75.34 million | Q2 2017: $86.54 million | Q3 2017: $110.67 million | Q1 2018: $242.98 million | Q2 2018: $274.38 million | Q3 2018: $299.75 million | Q1 2019: $320.21 million | Q2 2019: $328.68 million | Q3 2019: $367.02 million | Q1 2020: $445.49 million | Q2 2020: $497.82 million | Q3 2020: $534.13 million | Q1 2021: $552.40 million | Q2 2021: $568.48 million | Q3 2021: $585.40 million | Q1 2022: $468.12 million | Q2 2022: $496.36 million | Q3 2022: $533.26 million | Q1 2023: $617.85 million | Q2 2023: $524.63 million | Q3 2023: $594.02 million | Q1 2024: $655.94 million | Q2 2024: $714.56 million | Q3 2024: $784.26 million | Q1 2025: $846.46 million | Q2 2025: $801.72 million | Q3 2025: $823.61 million.
- Over the full 16 years of available data (2010 to 2025), CORCEPT THERAPEUTICS INC's Total Assets has grown by 3,232.7%.
- Historical annual values: Fiscal year 2025: $836.65 million | Fiscal year 2024: $840.55 million | Fiscal year 2023: $621.52 million | Fiscal year 2022: $583.43 million | Fiscal year 2021: $423.76 million | Fiscal year 2020: $571.73 million | Fiscal year 2019: $412.31 million | Fiscal year 2018: $311.69 million | Fiscal year 2017: $220.54 million | Fiscal year 2016: $68.75 million | Fiscal year 2015: $51.90 million | Fiscal year 2014: $34.63 million | Fiscal year 2013: $63.08 million | Fiscal year 2012: $99.17 million | Fiscal year 2011: $39.83 million | Fiscal year 2010: $25.10 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: